Metabolic effects of troglitazone in the Goto-Kakizaki rat, a non-obese and normolipidemic rodent model of non-insulin-dependent diabetes mellitus
- 28 February 1997
- journal article
- Published by Elsevier in Metabolism
- Vol. 46 (2), 192-198
- https://doi.org/10.1016/s0026-0495(97)90301-2
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Thiazolidinediones are novel insulin-sensitizing agentsCurrent Opinion in Endocrinology, Diabetes and Obesity, 1995
- Suppression of hepatic gluconeogenesis in long-term troglitazone treated diabetic KK and
C57BL KsJ-db db Metabolism, 1995 - Metabolic effects of troglitazone on fructose-induced insulin resistance in the ratDiabetes, 1994
- Improvement in Glucose Tolerance and Insulin Resistance in Obese Subjects Treated with TroglitazoneNew England Journal of Medicine, 1994
- Metabolic Effects of New Oral Hypoglycemic Agent CS-045 in NIDDM SubjectsDiabetes Care, 1992
- Characterization of CS-045, a new oral antidiabetic agent, II. Effects on glycemic control and pancreatic islet structure at a late stage of the diabetic syndrome in
C 57BL KsJ db db Metabolism, 1991 - Effect of New Oral Antidiabetic Agent CS-045 on Glucose Tolerance and Insulin Secretion in Patients with NIDDMDiabetes Care, 1991
- Actions of novel antidiabetic agent englitazone in hyperglycemic hyperinsulinemic ob/ob miceDiabetes, 1990
- Ciglitazone, a new hypoglycemic agent. I. Studies in ob/ob and db/db mice, diabetic Chinese hamsters, and normal and streptozotocin-diabetic ratsDiabetes, 1983
- Reduction of insulin resistance in obese and/or diabetic animals by 5-[4-(1-methylcyclohexylmethoxy)benzyl]-thiazolidine-2,4-dione (ADD-3878, U-63,287, ciglitazone), a new antidiabetic agentDiabetes, 1983